Dade Behring sets up Korean joint venture:
This article was originally published in Clinica
Executive Summary
Dade Behring has formed a joint venture with Handok Pharmaceutical in South Korea to market and distribute lab equipment and reagents. The new company, Dade Behring Handok Diagnostics, will market Dade Behring's full line of products as well as the Eppendorf brand of precision products and will replace the company's multiple distribution channels. Dade will be the majority owner of the new company. Handok's CEO and president, Young Kim, will be executive director of the new company, while Dade's Patrick Chiu will be general manager and representative director and KiHyun Koh of Handok's diagnostics division will be representative director and will handle on-site daily operations.